Mohler, James L.

The Androgen Axis in Recurrent Prostate Cancer

Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 675

Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005) · Clinical Cancer Research

Prostate Cancer Treatment and ResearchHormonal and reproductive studies

Cited by 488

Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.

Mahajan, N. P., Liu, Y., Majumder, S., Warren, M. R., Parker, C. E., Mohler, J. L., Earp, H. S., & Whang, Y. E. (2007) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchEstrogen and related hormone effects

Cited by 274

Castration-recurrent prostate cancer is not androgen-independent.

Mohler, J. L. (2008) · Advances in experimental medicine and biology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 106

High intratumoral CD8 + T‐cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy

Yang, Y., Attwood, K., Bshara, W., Mohler, J. L., Guru, K., Xu, B., Kalinski, P., & Chatta, G. (2021) · The Prostate

Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers

Cited by 88

Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells

Park, S.-Y., Kim, Y.-J., Gao, A. C., Mohler, J. L., Onate, S. A., Hidalgo, A. A., Ip, C., Park, E.-M., Yoon, S. Y., & Park, Y.-M. (2006) · Cancer Research

Prostate Cancer Treatment and ResearchCancer, Hypoxia, and Metabolism

Cited by 81